SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Schilke Tobin (as Filer) ↔ Revance Therapeutics, Inc.


        

List all Filings involving both

47  Filings
Filing emoji
 ·  Click on a Filing/Form Type¹
Filing/Form Type emoji
to view it
 ·  List the Documents
Document emoji
& Exhibits
Exhibit emoji
within them


        
Page:  
Page 1 emoji
  2   3   ·  All     
Bottom



        
Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing¹   For·On·As Docs:Size             Issuer                      Filing Agent      
Currently in descending order - Sort in ascending orderSort in ascending orderSort in ascending orderSort in descending orderSort in ascending orderSort in ascending order


        
 3/19/24  Schilke Tobin                     4          Officer²    1:6K   Revance Therapeutics, Inc.        Revance Theraps, Inc.    
 3/18/24  Schilke Tobin                     144                    1:5K   Revance Therapeutics, Inc.        Donnelley … Solutions/FA 
  3/4/24  Schilke Tobin                     4          Officer²    1:5K   Revance Therapeutics, Inc.        Revance Theraps, Inc.    
  2/2/24  Schilke Tobin                     4          Officer²    1:6K   Revance Therapeutics, Inc.        Revance Theraps, Inc.    
  1/3/24  Schilke Tobin                     4          Officer²    1:4K   Revance Therapeutics, Inc.        Revance Theraps, Inc.    
 8/15/23  Schilke Tobin                     4          Officer²    1:6K   Revance Therapeutics, Inc.        Revance Theraps, Inc.    
  7/5/23  Schilke Tobin                     4          Officer²    1:5K   Revance Therapeutics, Inc.        Revance Theraps, Inc.    
  7/3/23  Schilke Tobin                     144                    1:6K   Revance Therapeutics, Inc.        Morgan Stanley … Svcs/FA 
  6/5/23  Schilke Tobin                     4          Officer²    1:5K   Revance Therapeutics, Inc.        Revance Theraps, Inc.    
  6/2/23  Schilke Tobin                     144                    1:7K   Revance Therapeutics, Inc.        Morgan Stanley … Svcs/FA 
  6/1/23  Schilke Tobin                     144                    1:7K   Revance Therapeutics, Inc.        Morgan Stanley … Svcs/FA 
 5/16/23  Schilke Tobin                     4          Officer²    1:6K   Revance Therapeutics, Inc.        Revance Theraps, Inc.    
 5/12/23  Schilke Tobin                     144                    1:8K   Revance Therapeutics, Inc.        Donnelley … Solutions/FA 
  5/2/23  Schilke Tobin                     4          Officer²    1:4K   Revance Therapeutics, Inc.        Revance Theraps, Inc.    
  5/1/23  Schilke Tobin                     144                    1:6K   Revance Therapeutics, Inc.        Morgan Stanley … Svcs/FA 
  4/4/23  Schilke Tobin                     4          Officer²    1:4K   Revance Therapeutics, Inc.        Revance Theraps, Inc.    
 3/17/23  Schilke Tobin                     4          Officer²    1:4K   Revance Therapeutics, Inc.        Revance Theraps, Inc.    
  3/9/23  Schilke Tobin                     4          Officer²    1:6K   Revance Therapeutics, Inc.        Revance Theraps, Inc.    
  3/9/23  Schilke Tobin                     144                    1:7K   Revance Therapeutics, Inc.        Donnelley … Solutions/FA 
  3/2/23  Schilke Tobin                     4          Officer²    1:4K   Revance Therapeutics, Inc.        Revance Theraps, Inc.    
____________
 ¹  Filing/Form Types: 
Type emoji
  4    Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
  144    Notice of a Proposed Sale of Securities by an Insider — Form 144 { The Filer is an Insider² of the Issuer }.
 ²  Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.
 
Page:  
Page 1 emoji
  2   3   ·  All     
Top



        


Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 12:51:05.3am ET